• Skip to main content
  • Skip to footer
cnb1383_liver-model-drug-safety_webinar_nav-ad_v1
  • About us
  • News
  • Events
  • Careers
cn-bio-organ-on-a-chip-logo
  • Products
    • PhysioMimix® OOC Microphysiological Systems
    • Consumables
      • PhysioMimix® multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
    • Organ-on-a-chip models
    • Gut/Liver-on-a-chip
    • Lung-on-a-chip
    • Support packages
  • Applications
    • Disease modeling
    • Safety toxicology
    • ADME
  • Services
    • Non-Alcoholic Steatohepatitis
    • Drug-Induced Liver Injury
    • ADME
  • Technology
  • Resources
  • Company
    • About us
    • Events
    • News
    • Careers in Biotech
  • Contact us

Explore our solutions


PhysioMimix® is a suite of hardware, consumables and assay protocols that enable you to recreate complex human biology and accurately predict human drug responses.

PhysioMimix OOC

physiomimix-single-and-multi-organ-on-a-chip-systems
Learn more

Consumables

Multi-chip plates
3D validated cells
NASH-in-a-box
Bioavailability assay kit: Human 18
DILI assay kit: Human 24
Learn more

Models

Single-organ models
- Liver-on-a-chip model
- Lung-on-a-chip model
Multi-organ models
- Gut/Liver-on-a-chip models

Support packages

PhysioMimix® support packages

Discover the applications


Investigate the application areas that our PhysioMimix® products and services support

Learn more

Disease modeling

Metabolic dysfunction-associated steatohepatitis
Hepatitis B
Pulmonary infection
Learn more

Safety toxicology

Drug-induced liver injury
Immune-mediated liver injury
Learn more

ADME

Drug absorption
Drug metabolism
Drug bioavailability
Oligonucleotide delivery
Learn more

Studies as a service


Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks

Learn more
icon-nash-1-150x150.png MASLD/MASH
icon-dili-tox-150x150.png Drug-induced liver injury
icon-adme-150x150.png ADME

PhysioMimix® dual-organ plate

Investigate organ-to-organ crosstalk with our PhysioMimix Dual-organ plate


Each PhysioMimix Dual-organ plate enables six multi-organ systems to be created in vitro. Each system is comprised of two individually cultured organs that communicate via inter-organ fluidic flow.

Six independently grown biological barrier models (e.g., Lung-, or Gut-on-a-chip) are generated by culturing primary human cells on the apical and basolateral sides of a Transwell® insert. Six liver-on-a-chip models, consisting of primary human liver cells cocultured in 3D using an engineered scaffold, are grown in the liver compartment. An interconnected pneumatic pump facilitates communication between the two models.

Dual-organ models accurately recapitulate complex human systems, providing a human-relevant alternative to the use of animals.

Our plates are compatible with:

  • primary cells
  • induced-pluripotent stem cells
  • immortalized cell lines
  • circulating immune cells
  • precision-cut tissue slices
  • organoids

They are designed for use with the PhysioMimix Multi-organ System and can be used for a variety of applications.


How the Dual-organ plate works


PhysioMimix Dual-organ plate applications

Drug absorption

Drug metabolism

Drug bioavailability


Related consumables

3D validated cells

Bioavailability assay kit: Human 18


Learn more about PhysioMimix OOC
See other consumables
PhysioMimix® Dual-organ plate
PhysioMimix® Dual-organ plate well close up

Speak to our experts

Request a meeting with one of our OOC experts to see how our products and services can support your studies

Request a meeting

Footer

CN Bio logo

332 Cambridge Science Park, Milton Road
Cambridge, CB4 0WN

UK: +44 (0) 1223 737 941

US: +1 415 523 4005

Privacy | Cookies | Regulatory | Accessibility
Website terms | Terms of sale

Product Recycling

©2025 CN Bio Innovations Ltd
Registered No. ‍06517359. VAT No. GB978184563

Latest news

  • Microphysiological systems for mAbs development: how do they address animal limitations? May 1, 2025
  • Why the FDA animal testing phase-out for monoclonal antibodies? May 1, 2025
  • NIH to prioritize human-based research technologies & reduce animal use in research April 29, 2025
Cyber Essentials Logo